155 related articles for article (PubMed ID: 36156030)
21. [Infrastructure Required for Implementing Genomic Medicine and Expert Panel].
Kanai M
Gan To Kagaku Ryoho; 2019 Apr; 46(4):622-625. PubMed ID: 31164496
[TBL] [Abstract][Full Text] [Related]
22. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
[TBL] [Abstract][Full Text] [Related]
23. [Challenges in Expert Panel].
Yachida S
Gan To Kagaku Ryoho; 2022 Sep; 49(9):994-996. PubMed ID: 36156023
[TBL] [Abstract][Full Text] [Related]
24. Patient survey on cancer genomic medicine in Japan under the national health insurance system.
Kage H; Akiyama N; Chang H; Shinozaki-Ushiku A; Ka M; Kawata J; Muto M; Okuma Y; Okita N; Tsuchihara K; Kikuchi J; Shirota H; Hayashi H; Kokuryo T; Yachida S; Hirasawa A; Kubo M; Kenmotsu H; Tanabe M; Ushiku T; Muto K; Seto Y; Oda K
Cancer Sci; 2024 Mar; 115(3):954-962. PubMed ID: 38273803
[TBL] [Abstract][Full Text] [Related]
25. The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan.
Sunami K; Naito Y; Aimono E; Amano T; Ennishi D; Kage H; Kanai M; Komine K; Koyama T; Maeda T; Morita S; Sakai D; Kohsaka S; Tsuchihara K; Yoshino T
Int J Clin Oncol; 2021 Mar; 26(3):443-449. PubMed ID: 33385275
[TBL] [Abstract][Full Text] [Related]
26. [The Role of C-CAT, the Repository Database of Cancer Genomic Medicine in Japan].
Yoshida T
Gan To Kagaku Ryoho; 2019 Apr; 46(4):630-634. PubMed ID: 31164498
[TBL] [Abstract][Full Text] [Related]
27. [Roles of Pharmacists in Cancer Genomic Medicine].
Terada T
Yakugaku Zasshi; 2020; 140(5):663-666. PubMed ID: 32378668
[TBL] [Abstract][Full Text] [Related]
28. [The Role of Core Hospital of Cancer Genomic Medicine and Regional Cooperation].
Shirota H; Komine K
Gan To Kagaku Ryoho; 2020 Aug; 47(8):1149-1152. PubMed ID: 32829345
[TBL] [Abstract][Full Text] [Related]
29. [Current Status and Issues of Companion Diagnostics in Cancer Genomic Medicine].
Kanai M
Gan To Kagaku Ryoho; 2024 Apr; 51(4):388-391. PubMed ID: 38644302
[TBL] [Abstract][Full Text] [Related]
30. Access, autonomy, and affordability: ethical and human rights issues surrounding multigene panel testing for cancer in Japan and Switzerland.
Nakasato K; Manz C; Kato K
Front Genet; 2024; 15():1343720. PubMed ID: 38343692
[No Abstract] [Full Text] [Related]
31. Human resources for administrative work to carry out a comprehensive genomic profiling test in Japan.
Kage H; Oda K; Muto M; Tsuchihara K; Okita N; Okuma Y; Kikuchi J; Shirota H; Hayashi H; Kokuryo T; Sakai D; Hirasawa A; Kubo M; Kenmotsu H; Akiyama N; Shinozaki-Ushiku A; Tanabe M; Ushiku T; Miyagawa K; Seto Y
Cancer Sci; 2023 Jul; 114(7):3041-3049. PubMed ID: 37165760
[TBL] [Abstract][Full Text] [Related]
32. [Roles of Cancer Consultation Centers].
Sakamoto-Yamaguchi H
Gan To Kagaku Ryoho; 2021 Jan; 48(1):17-21. PubMed ID: 33468716
[TBL] [Abstract][Full Text] [Related]
33. Clinical utility of Todai OncoPanel in the setting of approved comprehensive cancer genomic profiling tests in Japan.
Kage H; Shinozaki-Ushiku A; Ishigaki K; Sato Y; Tanabe M; Tanaka S; Tanikawa M; Watanabe K; Kato S; Akagi K; Uchino K; Mitani K; Takahashi S; Miura Y; Ikeda S; Kojima Y; Watanabe K; Mochizuki H; Yamaguchi H; Kawazoe Y; Kashiwabara K; Kohsaka S; Tatsuno K; Ushiku T; Ohe K; Yatomi Y; Seto Y; Aburatani H; Mano H; Miyagawa K; Oda K
Cancer Sci; 2023 Apr; 114(4):1710-1717. PubMed ID: 36601953
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of comprehensive genomic profiling tests covered by public insurance in patients with advanced solid cancers in Hokkaido, Japan.
Kikuchi J; Ohhara Y; Takada K; Tanabe H; Hatanaka K; Amano T; C Hatanaka K; Hatanaka Y; Mitamura T; Kato M; Shibata Y; Yabe I; Endoh A; Komatsu Y; Matsuno Y; Sugiyama M; Manabe A; Sakurai A; Takahashi M; Naruse H; Torimoto Y; Dosaka-Akita H; Kinoshita I
Jpn J Clin Oncol; 2021 Apr; 51(5):753-761. PubMed ID: 33532831
[TBL] [Abstract][Full Text] [Related]
35. [Data-Sharing Systems of the Center for Cancer Genomics and Advanced Therapeutics(C-CAT)Repository Database and Expectation for the Future Medical Research and Development].
Suzuki T
Gan To Kagaku Ryoho; 2022 Nov; 49(11):1175-1182. PubMed ID: 36412016
[TBL] [Abstract][Full Text] [Related]
36. [Additional Remarks on the Issue of Cancer Genomic Medicine-Regarding Regional Disparity and Exit Strategies].
Kinoshita I
Gan To Kagaku Ryoho; 2022 Sep; 49(9):1008-1010. PubMed ID: 36156028
[TBL] [Abstract][Full Text] [Related]
37. [Clinical Application of Cancer Genome Diagnostics for Brain Tumors].
Takahashi M
No Shinkei Geka; 2021 May; 49(3):520-526. PubMed ID: 34092557
[TBL] [Abstract][Full Text] [Related]
38. Present status of germline findings in precision medicine for Japanese cancer patients: issues in the current system.
Higashigawa S; Matsubayashi H; Kiyozumi Y; Kado N; Nishimura S; Oishi T; Sugino T; Fushiki K; Shirasu H; Yasui H; Mamesaya N; Fukuzaki N; Kunitomo K; Horiuchi Y; Kenmotsu H; Serizawa M
Jpn J Clin Oncol; 2022 May; 52(6):599-608. PubMed ID: 35411369
[TBL] [Abstract][Full Text] [Related]
39. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
40. Current status and issues related to secondary findings in the first public insurance covered tumor genomic profiling in Japan: multi-site questionnaire survey.
Minamoto A; Yamada T; Shimada S; Kinoshita I; Aoki Y; Oda K; Ueki A; Higashigawa S; Morikawa M; Sato Y; Hirasawa A; Ogawa M; Kondo T; Yoshioka M; Kanai M; Muto M; Kosugi S
J Hum Genet; 2022 Oct; 67(10):557-563. PubMed ID: 35322199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
